His primary areas of investigation include Surgery, Lung cancer, Respiratory disease, Survival rate and Carcinoma. Chemotherapy is the focus of his Surgery research. His studies in Lung cancer integrate themes in fields like Randomized controlled trial, Radiation therapy and In situ hybridization.
His Respiratory disease research integrates issues from Stage, Angiogenesis and Vascular permeability. Joe B. Putnam has included themes like Magnetic resonance imaging and Chest pain in his Survival rate study. His Carcinoma research focuses on subjects like Oncology, which are linked to Tumor biology.
Surgery, Lung cancer, Internal medicine, Oncology and Radiology are his primary areas of study. His studies deal with areas such as Respiratory disease and Carcinoma as well as Surgery. Joe B. Putnam usually deals with Respiratory disease and limits it to topics linked to Metastasis and Sarcoma.
His Lung cancer study which covers Cancer that intersects with Biomarker. The Radiology study combines topics in areas such as Differential diagnosis and Resection. His studies examine the connections between Pneumonectomy and genetics, as well as such issues in Cardiothoracic surgery, with regards to Thoracotomy.
Joe B. Putnam mainly focuses on Lung cancer, Surgery, Internal medicine, Oncology and Radiology. His work carried out in the field of Lung cancer brings together such families of science as Cancer, Proportional hazards model, Stage, Prospective cohort study and Receiver operating characteristic. His research on Surgery often connects related topics like Pneumonectomy.
His study on Carcinoma, Phases of clinical research, Clinical trial and Lymphadenectomy is often connected to Panitumumab as part of broader study in Internal medicine. In his research, Docetaxel is intimately related to Radiation therapy, which falls under the overarching field of Oncology. His Radiology research is multidisciplinary, incorporating perspectives in Differential diagnosis and Confidence interval.
His primary scientific interests are in Lung cancer, Surgery, Internal medicine, Cardiothoracic surgery and Oncology. His research in Lung cancer intersects with topics in Immunohistochemistry, Cancer, Radiology, Prospective cohort study and Receiver operating characteristic. His biological study spans a wide range of topics, including Pneumonectomy, Lymph node and Pulmonary function testing.
His Cardiothoracic surgery study deals with Thoracotomy intersecting with Randomized controlled trial, Lung cancer surgery and Propensity score matching. His research integrates issues of Survival rate, Carcinoma, Lymphadenectomy and Lymph in his study of Oncology. His Survival rate research integrates issues from Carboplatin, Clinical endpoint, Chemotherapy and Hazard ratio.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
A Randomized Trial Comparing Perioperative Chemotherapy and Surgery With Surgery Alone in Resectable Stage IIIA Non-Small-Cell Lung Cancer
Jack A Roth;Frank V Fossella;Ritsuko Komaki;M. Bernadette Ryan.
Journal of the National Cancer Institute (1994)
Retrovirus-mediated wild-type p53 gene transfer to tumors of patients with lung cancer.
J. A. Roth;D. Nguyen;D. D. Lawrence;B. L. Kemp.
Nature Medicine (1996)
Morbidity and Mortality of Major Pulmonary Resections in Patients With Early-Stage Lung Cancer: Initial Results of the Randomized, Prospective ACOSOG Z0030 Trial
Mark S. Allen;Gail E. Darling;Taine T.V. Pechet;John D. Mitchell.
The Annals of Thoracic Surgery (2006)
Adenovirus-Mediated p53 Gene Transfer in Advanced Non-Small-Cell Lung Cancer
Stephen G. Swisher;Jack A. Roth;John Nemunaitis;David D. Lawrence.
Journal of the National Cancer Institute (1999)
Long-term follow-up of patients enrolled in a randomized trial comparing perioperative chemotherapy and surgery with surgery alone in resectable stage IIIA non-small-cell lung cancer
Jack A Roth;E.Neely Atkinson;Frank Fossella;Ritsuko Komaki.
Lung Cancer (1998)
Randomized trial of mediastinal lymph node sampling versus complete lymphadenectomy during pulmonary resection in the patient with N0 or N1 (less than hilar) non–small cell carcinoma: Results of the American College of Surgery Oncology Group Z0030 Trial
Gail E. Darling;Mark S. Allen;Paul A. Decker;Karla Ballman.
The Journal of Thoracic and Cardiovascular Surgery (2011)
Transthoracic vertebrectomy for metastatic spinal tumors
Ziya L. Gokaslan;Julie E. York;Garrett L. Walsh;Ian E. McCutcheon.
Journal of Neurosurgery (1998)
Effect of operative volume on morbidity, mortality, and hospital use after esophagectomy for cancer.
Stephen G. Swisher;Linda DeFord;Kelly Willis Merriman;Garrett L. Walsh.
The Journal of Thoracic and Cardiovascular Surgery (2000)
Survival in early-stage non-small cell lung cancer
Jonathan C. Nesbitt;Joe B. Putnam;Garrett L. Walsh;Jack A. Roth.
The Annals of Thoracic Surgery (1995)
Adenovirus-Mediated p53 Gene Transfer in Sequence With Cisplatin to Tumors of Patients With Non–Small-Cell Lung Cancer
J. Nemunaitis;S.G. Swisher;T. Timmons;D. Connors.
Journal of Clinical Oncology (2000)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: